Lifeboat Foundation

A new brain-computer interface translates neurological signals into complete sentences.

Researchers are edging closer to a therapy for Angelman syndrome that involves injecting molecules that can edit genes into the fetal brain. They have already succeeded in mice and say the approach could eventually treat people with the syndrome.

The work is of high interest because a similar strategy could also work for other genetic conditions linked to autism.

But the prospect of injecting molecules into fetal brains poses ethical questions, experts caution.

Continue reading “Injecting CRISPR into fetal brain may correct autism mutations” »

Worldwide, 50 million people are living with Alzheimer’s disease and other dementias. According to the Alzheimer’s Association, every 65 seconds someone in the United States develops this disease, which causes problems with memory, thinking and behavior.

It has been more than 100 years since Alois Alzheimer, M.D., a German psychiatrist and neuropathologist, first reported the presence of senile plaques in an Alzheimer’s disease patient brain. It led to the discovery of amyloid precursor protein that produces deposits or plaques of amyloid fragments in the brain, the suspected culprit of Alzheimer’s disease. Since then, amyloid precursor protein has been extensively studied because of its association with Alzheimer’s disease. However, amyloid precursor protein distribution within and on neurons and its function in these cells remain unclear.

A team of neuroscientists led by Florida Atlantic University’s Brain Institute sought to answer a fundamental question in their quest to combat Alzheimer’s disease—” Is amyloid precursor protein the mastermind behind Alzheimer’s disease or is it just an accomplice?”

Continue reading “Scientists propose new theory on Alzheimer’s, amyloid connection” »

A woman has regained full consciousness after 28 years in a vegetative state. Munira Abdulla suffered a severe brain injury a car crash in the United Arab Emirates (UAE) in 1991 – when she was 32. “I never gave up on her because I always had a feeling that one day she will wake up,” her son Omar Webair.

In multiple sclerosis, the body’s immune system attacks and damages myelin, which is the insulating layer on nerves in the spinal cord, brain and optic nerve. This causes the nerves to short-circuit and cease functioning properly. In “a potential game-changer,” scientists have now demonstrated that a synthetic molecule can restore compromised myelin.

Ecstadelic Media Group releases a new non-fiction book The Origins of Us: Evolutionary Emergence and The Omega Point Cosmology by Alex M. Vikoulov as a Kindle ebook (Press Release, San Francisco, CA, USA, April 22, 2019 01.00 PM PST)

The Science and Philosophy of Information book series is adapted for general audience and based on the previously published grand volume titled “ The Syntellect Hypothesis: Five Paradigms of the Mind’s Evolution” by digital philosopher Alex Vikoulov on the ultimate nature of reality, consciousness, the physics of time, and philosophy of mind. In this book one of the series, the author addresses some of the most flaming questions in science and philosophy: Where do we come from? What are the origins of us? What is our role in the grand scheme of things?

“# 1 Hot New Release” in Amazon charts in Cosmology and Evolution, the book starts with a story that happened almost exactly 400 years ago that has had a tremendous “butterfly” effect on us modern humans.

Continue reading “The Origins of Us: Evolutionary Emergence and The Omega Point Cosmology — A New Book That Makes You Question The Nature of Reality but Provides You with Surprising Answers | Press Release” »

21 votes and so far on Reddit.

…from 2017/2018 that helped me understand the creation of Master Splinter.

Inserting human “mini-brains” into rodents has the potential to broaden scientists’ understanding of neurological disease, but raises quandaries about consciousness.

Arab American University congrats and is proud of Dr. Thabat Al-Khatib and researcher in Applied Neuroscience, Dr. Al-Khatib graduated from the Faculty of Sciences and Arts at Arab American University in 2012. She succeeded to add her name on the list of innovators in Britain after the invention of a drug treatment for Alzheimer’s disease and received two patents.

Al Khatib is currently working at the University of Aberdeen – Faculty of Medicine as a researcher in Neuroscience dept. and aspires to be a lecturer in Palestine to add value to students and the community.

Al-Khatib said commenting on the two inventions:

Continue reading “The University Is Proud and Congratulates Its Graduate Dr. Thabat Al-khatib and Researcher in Applied Neuroscience for Receiving Two Patents of Medicine for the Treatment of Alzheimer’s Disease” »